Tandem Diabetes Care (TNDM) EBT (QoQ) (2013 - 2026)
Tandem Diabetes Care (TNDM) EBT (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -520.90% |
| Dec 31, 2025 | 118.80% |
| Sep 30, 2025 | 56.44% |
| Jun 30, 2025 | 52.73% |
| Mar 31, 2025 | -763,225.00% |
| Dec 31, 2024 | 100.07% |
| Sep 30, 2024 | 23.97% |
| Jun 30, 2024 | 24.76% |
| Mar 31, 2024 | -26.25% |
| Dec 31, 2023 | -1.89% |
| Sep 30, 2023 | 11.19% |
| Jun 30, 2023 | 72.01% |
| Mar 31, 2023 | -665.23% |
| Dec 31, 2022 | 65.89% |
| Sep 30, 2022 | -265.63% |
| Jun 30, 2022 | 21.22% |
| Mar 31, 2022 | -248.09% |
| Dec 31, 2021 | 91.40% |
| Sep 30, 2021 | 41.46% |
| Jun 30, 2021 | 178.85% |